80岁及以上急性心肌梗死患者介入治疗进展

Progress of percutaneous coronary intervention in acute myocardial infarction patients aged 80 years and above

冠状动脉疾病是80岁及以上人群心血管死亡的主要原因,随着人口老龄化日益加深,老年患者在心血管疾病患者中的比例快速增长,由于其年龄和临床特点,其再灌注治疗面临更高的风险和挑战。目前,关于这类人群的临床试验数据有限,针对80岁及以上患者是否应该接受介入治疗目前仍存在争议,本文就80岁及以上急性心肌梗死患者介入治疗进展进行阐述。

Coronary artery disease is the leading cause of cardiovascular death in elderly people who aged 80 years and above.With the increasing aging of the population,the proportion of elderly patients with cardiovascular disease is growing rapidly.The risk of reperfusion therapy is high due to the age and their clinical characteristics.At present,there are limited clinical data on this population,and there is still a controversy about the decision of reperfusion therapy.This article will review the progresses of interventional therapy in patients with acute myocardial infarction aged 80 and above.